Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Nuveen New York Muni Value Fund 2 (NYV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	NYV
Company	Nuveen New York Muni Value Fund 2
Price Information
Exchange	NYSE
Open	15.03
High	15.14
Low	15.03
Latest	15.04
Change	+0.02
% Change	+0.13%
Volume	13,800
20-Day Average Volume	6,810
Previous Close	15.02
Industry	N/A
Has Options	No
Technicals
20-Day Moving Average	14.70
20-Day Raw Stochastic	83.87%
20-Day Relative Strength	62.90
Weighted Alpha	+9.22
Today's Opinion	40% Buy
Previous Opinion	40% Buy
Last Month's Opinion	24% Sell
Performance
5-Days
%Chg	+1.96% since 04/01/21
Low	14.70 on 04/07/21
High	15.14 on 04/09/21
1-Month
%Chg	+3.37% since 03/09/21
Low	14.52 on 03/17/21
High	15.14 on 04/09/21
3-Month
%Chg	+1.62% since 01/08/21
Low	14.20 on 03/01/21
High	15.14 on 04/09/21
6-Month
%Chg	+1.62% since 10/09/20
Low	14.20 on 03/01/21
High	15.14 on 04/09/21
Key Statistics
Market Capitalization, $K	N/A
Shares Outstanding, K	N/A
Annual Sales	3,994,099
Annual Net Income	3,922,722
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	N/A
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	N/A
Most Recent Dividend	N/A
Next Ex-Dividends Date	04/08/21
Ratios
Price/Earnings ttm	N/A